This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
1, 2024 — The Centers for Medicare & Medicaid Services (CMS) have announced a significant adjustment to the Hospital Outpatient Prospective Payment System (HOPPS). However, under the previous reimbursement system, diagnostic radiopharmaceuticals were bundled as “supplies,” limiting access in several ways.
The 2025 conversion factor (CF) that sets the overall rate for the Medicare Physician Fee Schedule (MPFS) was adjusted downward by 2.83% from the 2024 rate, to $32.3465 per RVU vs. $33.2875 per Relative Value Unit (RVU). 879, the Medicare Patient Access and Practice Stabilization Act of 2025, has been introduced but no action has been taken.
Leonel Ferreira, MD, a full member of the Brazilian College of Radiology and Diagnostic Imaging, was one of eight doctors and 62 others who died August 9 in the crash. Those who specialized -- particularly in CT, MRI, neuroimaging, and nuclearmedicine/PET -- earned more.
Centers for Medicare and Medicaid Services (CMS) has issued its proposal for payments in 2025 under the Physician Fee Schedule (PFS), and it contains an across-the-board 2.8% This reduction in payments continues a trend that has seen the Medicare fee schedule reduced by nearly 10% over the past 10 years. Radiology -3.8% -1.8% -2.8%
Centers for Medicare and Medicaid Services (CMS) proposed a new reimbursement plan July 10 for diagnostic PET scans that would provide separate payments for radiopharmaceuticals, as well as an extra payment for hospitals when they use domestically produced technetium-99m (Tc-99m).
Higher Medicaid-to-Medicare reimbursement ratios (MMRR) are linked to increased likelihood of Medicaid patients receiving CT, MR, ultrasound, and x-ray imaging, researchers have reported. Medicare reimbursement levels are set by individual states, and they vary across the U.S., Nuclearmedicine 0.76 Ultrasound 0.85
Centers for Medicare and Medicaid Services (CMS) announced on October 13 that it has lifted its coverage limit of one beta-amyloid PET scan per lifetime for patients with Alzheimer’s disease. Medicare coverage decisions for amyloid PET scans will now be made by local Medicare Administrative Contractors (MACs).
The large differences between radiologists and nonradiologists in interpretation training could lead to differences in diagnostic accuracy." million office-based imaging claims for Medicare fee-for-service beneficiaries in 2022 that were ordered by nonradiologists. Ultrasound 52% Nuclearmedicine 39.5%
Radiology practices often participate in the Medicare Quality Payment Program (QPP) through the Merit-based Incentive Payment System (MIPS). Centers for Medicare and Medicaid Services (CMS) has made a change to remove that cap, which means that such measures will receive the full 10 points. The completeness criteria remain at 75%.
As nuclearmedicine therapies gain stature compared to nuclearmedicine in diagnostic imaging, hospital administrators may be eyeing the potential of adding theranostics services. A shortage of nuclearmedicine technologists means a theranostics center may need to limit its patient volume.
Centers for Medicare & Medicaid Services (CMS) 2025 Medicare Physician Fee Schedule (MPFS) and Hospital Outpatient Prospective Payment System (HOPPS) final rules. ASTRO also supports short-term relief established through the Medicare Patient Access and Practice Stabilization Act, which would eliminate the looming 2.8%
initiative to secure domestic supplies of molybdenum-99, according to an official who spoke at a National Nuclear Security Administration (NNSA) meeting October 9 in Arlington, VA. Mo-99’s daughter decay chain isotope is technetium-99m (Tc-99m), which is used in an estimated 40,000 diagnosticnuclearmedicine exams each day.
Centers for Medicare and Medicaid Services (CMS) proposed a new reimbursement plan July 10 for diagnostic PET scans that would provide separate payments for radiopharmaceuticals, as well as an extra payment for hospitals when they use domestically produced technetium-99m (Tc-99m).
Centers for Medicare and Medicaid Services (CMS) proposed Medicare Physician Fee Schedule (MPFS) 2025 rule. The organization noted that the CMS expects the overall impact of the proposed MPFS to be neutral on radiology, nuclearmedicine, and radiation oncology. The American College of Radiology has weighed in on the U.S.
After analyzing Medicare billing data from 2019 to 2024, researchers from NYU Langone Health in New York City found that radiologists have a lower national attrition rate than other healthcare providers. Emergency medicine physicians: 26.6% Medicine subspecialists: 12.9% according to research published July 23 in Radiology.
The Society of NuclearMedicine and Molecular Imaging (SNMMI) presented its 2025 Legislative Champion Award to Representatives Neal Dunn, MD, and Ami Bera, MD. Centers for Medicare and Medicaid (CMS) to update the Hospital Outpatient Prospective Payment System (HOPPS) in 2025 by unbundling radiopharmaceuticals.
Over the years medical imaging has been considered a major contributor to increased healthcare spending, and has been subject to a variety of cost-cutting measures that have been mostly aimed at reducing Medicare and Medicaid costs. to identify noninvasive diagnostic imaging services in this data. Nuclearmedicine 2.7%
Nuclear cardiologists could see significant reductions in Medicare reimbursements in 2025, according to a leading expert. Nuclear cardiologists need to be aware of the potential negative financial impact and plan accordingly, Phillips said. Despite a proposal by the U.S.
With the passage of the Consolidated Appropriations Act, 2024 (CAA 24) , we finally learned the rates physicians will be paid for Medicare services during the remainder of 2024. This makes the Medicare payment rate 1.77% lower than it was in 2023, rather than the 3.37% cut that was contained in the 2024 MPFS Final Rule.
While radiologists interpreted approximately 99 percent of all non-cardiac CT, MRI and nuclearmedicine studies in hospital and emergency department settings for Medicare beneficiaries, new research shows significantly less radiologist review of cardiac imaging and office-based imaging.
In a review of over 1,630,000 office-based non-breast imaging Medicare fee-for-service (FFS) claims from 2022, researchers found that 39.5 percent of nuclearmedicine imaging were interpreted by ordering clinicians.
Scientific Paper of the Year Advanced Practice Provider Procedures Commonly Performed in Interventional Radiology: Medicare Volume Trends From 2010 to 2021. Central Vein Sign in Multiple Sclerosis: A Comparison Study of the Diagnostic Performance of 3T versus 7T MRI. Luthria, et al, Journal of NuclearMedicine , October 26, 2023.
This can only be accomplished with a combination of innovative diagnostic, treatment, and monitoring technology that can enable timely interventions and personalized treatment plans. More accurate diagnostic and monitoring tools can also help manage the high cost of new therapies by preventing the misuse of expensive treatments.
30, 2025 Earlier this month, the Society of NuclearMedicine and Molecular Imaging (SNMMI) and the Alzheimers Association released updated appropriate use criteria (AUC) for amyloid and tau PET imaging in patients with mild cognitive impairment, Alzheimers disease and other dementias. tim.hodson Thu, 01/30/2025 - 10:20 Jan.30,
Diagnostic imaging is a necessary medical tool, but it must be used with great care," said Joint Commission President Dr. Mark Chassin in a statement accompanying the release of the alert. Centers for Medicare and Medicaid Services (CMS) that begins in January 2012.
POSLUMA is now commercially available through multiple radiopharmacies of PETNET Solutions, the primary manufacturer and commercial distributor for Blue Earth Diagnostics in the United States. Chief Executive Officer of Blue Earth Diagnostics Ltd. Blue Earth Diagnostics is at Booth 6025 and PETNET Solutions is at Booth 6075.
Capitol Imaging Services is one of a select number of diagnostic facilities equipped to perform Low-Dose CT (Computed Tomography) lung cancer screenings. Some insurance companies, like Medicare, will only cover a CT lung cancer screening if you meet a certain criteria.
This is slightly more of a cut than had been predicted in the Medicare Physician Fee Schedule (MPFS) Proposed Rule that was issued in July. As we reported in our analysis of the Proposed Rule , this reduction in payments continues a trend that has seen the Medicare fee schedule reduced by nearly 10% over the past 10 years.
The Society of NuclearMedicine and Molecular Imaging (SNMMI) and the Alzheimers Association have released new appropriate use criteria for brain PET imaging of amyloid and tau pathology related to cognitive impairment and Alzheimers disease. Since then, the U.S. There are three PET radiotracers labeled with F-18 approved by the U.S.
8, 2025 The Society of NuclearMedicine and Molecular Imaging (SNMMI) and the Alzheimers Association have released updated appropriate use criteria (AUC) for amyloid and tau PET imaging in patients with mild cognitive impairment, Alzheimers disease and other dementias. tim.hodson Tue, 01/14/2025 - 16:48 Jan.8, Since then, the U.S.
We organize all of the trending information in your field so you don't have to. Join 5,000 users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content